June 15, 2018

Dr. Andreas Heczey’s GD2 Specific CAR and Interleukin-15 expressing autologous NKT cells to treat children with neuroblastoma recently opened and is recruiting Dr. Heczey is at Texas children’s hospital/Baylor College of medicine. To learn more about trial here’s a link to the trial at clinical trials.gov:

https://clinicaltrials.gov/ct2/show/NCT03294954?term=NKT&cond=Neuroblastoma&rank=1

Dr. Heczey’s email: axheczey@txch.org